ASCO 2026 marked a clear inflection point in oncology. Brooks Hill Partners breaks down the meeting's defining themes — from pan-KRAS inhibitors unlocking treatment in pancreatic cancer, to bispecific antibodies expanding immunotherapy's reach, and ADCs emerging as a cornerstone of next-generation combination strategies. Underlying it all: a growing imperative to translate scientific breakthroughs into globally equitable access.

Metabolism is a complex process that facilitates the breakdown of nutrients to generate energy and the production of molecules crucial for c